What did @filmedwithvictoria actually say?
The creator shared a personal peptide routine, mentioning they dose "Monday, Wednesday, Friday" at "0.25 milligrams," sourcing from vendors including "Limitless Life" and "Reddot" (likely the brands referenced, given audio distortion in the transcript). They stressed doing research, using AI tools like ChatGPT for information, and cautioned viewers to be careful. They also mentioned that peptides "have a half-life" as justification for their dosing schedule.
The video is a personal experience share, not a clinical tutorial. That framing matters when we evaluate what was actually said versus what viewers might take away. The creator repeatedly says "everyone's different" and "your journey's different," which is at least an honest disclaimer. What they did not say: they did not name which specific peptide they are using. The transcript refers to "peppers" throughout, which appears to be slang, likely for peptides broadly. Without knowing the specific compound, some claims become harder to evaluate precisely.
Does the science back this up?
The half-life point is accurate in principle, but the way it is applied here oversimplifies pharmacokinetics considerably. Different peptides have wildly different half-lives, and that alone does not determine an optimal dosing schedule.
Peptide half-lives vary from minutes to hours depending on the compound. BPC-157, for instance, has a relatively short half-life estimated at around 4 hours in some animal models (Chang et al., 2011, Current Pharmaceutical Design). CJC-1295, a GHRH analogue, has a much longer half-life of around 6-8 days when combined with DAC (Drug Affinity Complex), which is precisely why it is typically dosed weekly or twice weekly, not because of a generic half-life principle (Teichman et al., 2006, Journal of Clinical Endocrinology and Metabolism). Ipamorelin, by contrast, has a half-life of roughly 2 hours, meaning a Monday-Wednesday-Friday schedule would be pharmacologically irrelevant if someone were using it for acute GH pulses.
The creator's logic, that a half-life justifies a MWF schedule, is not wrong in a broad sense, but it is not specific enough to be genuinely useful guidance.
What did they get wrong (or right)?
They got the general caution right. Saying "you need to do a ton of research" and "be very careful" before using unregulated compounds is the correct instinct, even if it does not go far enough.
What they got wrong, or at least imprecise: recommending ChatGPT as an information source for peptide therapy is genuinely problematic. Large language models hallucinate citations, get dosing ranges wrong, and cannot account for your individual health status. A 2023 study by Alkaissi and McFarlane (JMIR Medical Education) found that ChatGPT fabricated plausible-sounding but nonexistent medical references at a notable rate. Using it to guide injection protocols is a real risk.
The sourcing recommendations are unverifiable on our end. Purchasing peptides from research chemical vendors means you are receiving compounds with no FDA oversight, no guaranteed purity, and no sterility verification. Third-party certificates of analysis exist, but they are not equivalent to pharmaceutical-grade manufacturing standards. The creator does not mention any of this.
Sharing a specific dose of "0.25 milligrams" without naming the compound is particularly concerning. That dose is reasonable for some peptides and potentially insufficient or irrelevant for others. Context matters enormously here.
What should you actually know?
Peptide therapy operates in a regulatory gray zone. Some peptides like sermorelin and tesamorelin are FDA-approved drugs. Others like BPC-157 and TB-500 are sold as research chemicals with no approved human indication. That distinction carries real legal and safety weight.
The FDA placed BPC-157 and TB-500 on its list of bulk drug substances that cannot be used in compounding in 2023, which means even licensed compounding pharmacies in the U.S. cannot legally make them for human use. That does not mean people have stopped using them, but it does mean there is no regulated supply chain for these compounds.
Half-life is one factor in dosing schedules, but it is not the only one. Receptor desensitization, saturation kinetics, and individual pharmacogenomics all play roles. A MWF schedule may work for someone using a specific compound for specific reasons, but the reasoning the creator gives, "it has a half-life," is too thin to generalize.
If you are considering any peptide protocol, a licensed healthcare provider with actual training in peptide pharmacology is the appropriate starting point. Not Reddit. Not TikTok. Not ChatGPT.